Výsledky vyhledávání - "Sandra Gazel"

Impact of Adalimumab Patient Support Program’s Care Coach Calls on Clinical Outcomes in Patients with Crohn’s Disease in Canada: An Observational Retrospective Cohort Study

Autor: Krishna Donepudi, Tania Gaetano, Martin G. Latour, Katia Charland, Brad Millson, Kevin McHugh, Sandra Gazel, John Marshall, Marie-Claude Laliberté, Neeraj Narula

Publikováno v: Journal of the Canadian Association of Gastroenterology

Background Adalimumab is an antitumour necrosis factor (TNFα) biologic therapy indicated for the treatment of Crohn’s disease (CD). Patients receiving adalimumab in Canada are eligible to enroll in the AbbVie Care™ patient support program (AC-PS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c8d281258a7f950c440fadb3395b0c8
http://europepmc.org/articles/PMC6542296

Zobrazit plný text záznamu

Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study

Autor: Marie-Claude Laliberté, Sandra Gazel, Gerald Lebovic, Martin G. Latour, Louis Bessette, Neil H. Shear, Brad Millson, J. Carter Thorne, Tania Gaetano, Jennifer Glass, John Marshall

Publikováno v: Clinical Therapeutics. 40:1024-1032

The aim of this study was to quantify the association between receiving care-coach calls (CCCs), a service provided by a patient-support program (PSP) in Canada, and persistence with and adherence to adalimumab therapy over a 3-year period in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73139e3a014d1cb492765bdf0cb53c46
https://doi.org/10.1016/j.clinthera.2018.04.017

Zobrazit plný text záznamu

Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study

Autor: Sandra Gazel, Carter Thorne, Martin G. Latour, V. Remple, Marie-Claude Laliberté, Krishna Donepudi, Tania Gaetano, Gerald Lebovic, Louis Bessette, Katia Charland, Brad Millson

Publikováno v: Rheumatology and Therapy. 5:75-85

Adalimumab (ADA) is a tumor necrosis factor (TNF)-alpha inhibitor indicated for the treatment of inflammatory autoimmune diseases, including ankylosing spondylitis (AS). Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care™ pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500e8aed1d179938271678f62bc4b382
https://doi.org/10.1007/s40744-018-0109-3

Zobrazit plný text záznamu

Plný text ve formátu HTML

Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort Study

Autor: Sebastien K. Gerega, Louis Bessette, Driss Oraichi, Gerald Lebovic, Brad Millson, Martin G. Latour, Neil H. Shear, Marie-Claude Laliberté, Sandra Gazel, Tania Gaetano, John Marshall, Carter Thorne

Publikováno v: Clinical Therapeutics. 40:415-429.e6

Adalimumab (ADA) is a tumor necrosis factor-α inhibitor indicated for use in various immune-mediated inflammatory diseases. Patients receiving ADA in Canada are eligible to enroll in the AbbVie Care's Patient Support Program (PSP), which provides pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00977b032be4455a19e9f4d38b596c8f
https://doi.org/10.1016/j.clinthera.2018.02.001

Zobrazit plný text záznamu

Canadian Study of Outcomes in Adalimumab Patients with Support for Adherence: Results from the COMPANION Study

Autor: Gerald Lebovic, Driss Oraichi, John Marshall, Sandra Gazel, Marie-Claude Laliberté, Louis Bessette, Martin G. Latour, Brad Millson, Sebastien K. Gerega, Michael Sung, Tania Gaetano

Publikováno v: American Journal of Gastroenterology. 111:S446

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::faa6c241e7968c6203092992a42d4832
https://doi.org/10.14309/00000434-201610001-01023

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání